Systemic refractive myasthenia

• 收藏
• 分享

专利权人:

ИНК. (US);АЛЕКСИОН ФАРМАСЬЮТИКАЛС

发明人:

БЕДРОСИАН, Камилле (US),ОБРАЙЕН, Фанни (US),ВАН, Цзин, Цзин (US)

申请号：

RU2018141451

公开号：

RU2018141451A

申请日:

2017.05.15

申请国别(地区):

RU

年份:

2020

代理人:

摘要：

The disclosure provides methods of treating myasthenia gravis (MG) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/